This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Corine Gessier-Vial: Innovator in Phosphate Adsorbent Technology
Introduction
Corine Gessier-Vial is an accomplished inventor based in Altkirch, France. She has made significant contributions to the field of pharmaceutical innovations, particularly in the treatment of hyperphosphataemia. With a focus on developing effective solutions, Gessier-Vial holds one patent that underscores her inventive spirit.
Latest Patents
Corine Gessier-Vial's recent patent is centered around a manufacturing process for a novel iron-containing phosphate adsorbent. This innovative technology offers potential applications for treating hyperphosphataemia, a condition characterized by elevated phosphate levels in the blood. Her patent represents a significant advancement in the field and highlights her commitment to improving patient outcomes.
Career Highlights
Corine is currently associated with Novartis AG, a leading global healthcare company. Through her work at Novartis, she has been able to translate her inventive ideas into tangible products that can benefit patients. Her dedication to research and development within the pharmaceutical sector showcases her role as a key contributor to innovative healthcare solutions.
Collaborations
Throughout her career, Corine Gessier-Vial has collaborated with several talented professionals, including Michael Ambühl and Christa Hartmann. These partnerships have allowed her to enhance her work, fostering an environment of creativity and shared expertise that is essential for driving innovation in the pharmaceutical industry.
Conclusion
Corine Gessier-Vial stands out as a significant figure in the realm of inventions related to healthcare. Her patent for a new phosphate adsorbent reflects her commitment to advancing treatment options for patients. As she continues her work at Novartis AG and collaborates with other experts, her contributions are likely to have a lasting impact on the industry and the lives of those affected by hyperphosphataemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
